NFKBIL2 / IKBR antibody
Principal name
NFKBIL2 / IKBR antibody
Alternative names for NFKBIL2 / IKBR antibody
Tonsoku-like protein, TONSL, I-kappa-B-related protein, IkappaBR, NF-kappa-B inhibitor-like protein 2, Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 2, Inhibitor of kappa B-related protein
Ncbi ID
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), ELISA (detection) (E(detection)), Paraffin Sections (P)
Background of NFKBIL2 / IKBR antibody
- Kit Component:
- - KN318056G1, Nfkbil2 gRNA vector 1 in pCas-Guide vector
- KN318056G2, Nfkbil2 gRNA vector 2 in pCas-Guide vector
- KN318056D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Ewing,R.M., Mol. Syst. Biol. 3, 89 (2007)
Western Blot analysis of NFKBIL2 expression in transfected 293T cell line (H00004796-T01) by NFKBIL2 MaxPab polyclonal antibody.Lane 1: NFKBIL2 transfected lysate(134.09 KDa).Lane 2: Non-transfected lysate.
Human 293T; WB Suggested Anti-NFKBIL2 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:62500. Positive Control: 293T cell lysate; NFKBIL2 antibody - middle region (P100874_P050) in Human 293T cells using Western Blot
Predicted cell location: Nucleus. Positive control: Human ovarian cancer and brain tissue. Recommended dilution: 1/100-300 The image on the left is immunohistochemistry of paraffin-embedded human ovarian cancer tissue using TONSL antibody at dilution 1/60, on the right is treated with the fusion protein. (Original magnification:x 200)
Predicted cell location: Nucleus. Positive control: Human ovarian cancer and brain tissue. Recommended dilution: 1/100-300 The image on the left is immunohistochemistry of paraffin-embedded human brain tissue using TONSL antibody at dilution 1/60, on the right is treated with the fusion protein. (Original magnification: x200)
Predicted cell location: Cytoplasm. Positive control: Human brain and liver cancer tissue. Recommended dilution: 1/50-200 The image on the left is immunohistochemistry of paraffin-embedded human brain tissue using TONSL antibody at dilution 1/45, on the right is treated with the fusion protein. (Original magnification:x 200)
Predicted cell location: Cytoplasm. Positive control: Human brain and liver cancer tissue. Recommended dilution: 1/50-200 The image on the left is immunohistochemistry of paraffin-embedded human liver cancer tissue using TONSL antibody at dilution 1/45, on the right is treated with the fusion protein. (Original magnification:x200)
WB Suggested Anti-NFKBIL2 Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1:62500; Positive Control: 293T cell lysate
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA322397 | NFKBIL2 / IKBR antibody |
||||||
| Anti-TONSL Rabbit Polyclonal Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt | E, P |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
 +1 additional image |
|||||||
| TA322398 | NFKBIL2 / IKBR antibody |
||||||
| Anti-TONSL Rabbit Polyclonal Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt | E, P |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| +1 additional image |
|||||||
| TA330108 | NFKBIL2 / IKBR antibody |
||||||
| Rabbit Polyclonal Anti-TONSL Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu | WB |
50 µg /
€360.00
|
|
| OriGene Technologies, Inc. | |||||||
CRISPR
| Catalog No. | Species | Donor Vector | |
|---|---|---|---|
| KN201046 | TONSL - human gene knockout kit via CRISPR |
||
 |
Human | GFP-Puro |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN201046BN | TONSL - human gene knockout kit via CRISPR |
||
|
Human | mBFP-Neo |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN201046LP | TONSL - human gene knockout kit via CRISPR |
||
|
Human | Luciferase-Puro |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN201046RB | TONSL - human gene knockout kit via CRISPR |
||
|
Human | RFP-BSD |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN318056 | Tonsl - mouse gene knockout kit via CRISPR |
||
|
Mouse | GFP-Puro |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN318056BN | Tonsl - mouse gene knockout kit via CRISPR |
||
|
Mouse | mBFP-Neo |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN318056LP | Tonsl - mouse gene knockout kit via CRISPR |
||
|
Mouse | Luciferase-Puro |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN318056RB | Tonsl - mouse gene knockout kit via CRISPR |
||
|
Mouse | RFP-BSD |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
Lysates
| Catalog No. | ||
|---|---|---|
| LY415543 | TONSL overexpression lysate |
|
|
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |
Human Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RC201046L2V | Lenti ORF particles, TONSL (mGFP-tagged)-Human tonsoku-like, DNA repair protein (TONSL), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€2,606.00
|
|
| OriGene Technologies, Inc. | ||
| RC229437L2V | Lenti ORF particles, TONSL (mGFP-tagged)-Human tonsoku-like, DNA repair protein (TONSL), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€2,606.00
|
|
| OriGene Technologies, Inc. | ||
| RC201046L1V | Lenti ORF particles, TONSL (Myc-DDK-tagged)-Human tonsoku-like, DNA repair protein (TONSL), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€2,349.00
|
|
| OriGene Technologies, Inc. | ||
| RC229437L1V | Lenti ORF particles, TONSL (Myc-DDK-tagged)-Human tonsoku-like, DNA repair protein (TONSL), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€2,349.00
|
|
| OriGene Technologies, Inc. | ||
